Platts corrects Nov. 21 EMEA Urals and Med Brent Crude Daily Rationales and Exclusions

Platts, part of S&P Global Energy, has corrected the EMEA Urals and Med Brent Crude Daily Rationales and Exclusions for Nov. 21.

The Nov. 21 rationale should read as follows:

Urals CIF Augusta differential <AAGXX00> assessment rationale:

Platts assessed Urals CIF Augusta $1.08/b lower. There were no bids or offers in the Platts Market on Close assessment process. The Urals CIF Augusta differential was assessed using a net forward to the Urals FOB Aframax and Suezmax assessment. The FOB differentials were assessed $1/b lower, reflecting weakening market fundamentals observed throughout the day.

Urals CIF Med <PCACE00> assessment rationale:

The Urals CIF Mediterranean assessment reflected the value of the Mediterranean Dated Brent Strip (AALDF00) plus the Urals CIF Augusta differential assessment (AAGXX00).

Urals RCMB (Recombined) <AALIN00> assessment rationale:

The Urals RCMB (Recombined) assessment reflected the value of the Platts Dated Brent assessment (PCAAS00) plus the Urals CIF Augusta differential assessment (AAGXX00).

Urals CIF Rdam <PCAFW00> assessment rationale:

Platts assessed Urals CIF Rotterdam $1/b lower. There were no bids or offers in the MOC. The Urals CIF Rotterdam differential was assessed as a net forward to the Urals FOB Baltic assessment. The FOB differentials were assessed $1/b lower, reflecting weakening market fundamentals observed throughout the day.

Med Dated Brent Strip 13-28 Day <AALDF00> assessment rationale:

The Mediterranean Dated Brent Strip reflected the value of Forward Dated Brent 13-28 days ahead of the day of publication. Forward Dated Brent is assessed as a function of Platts assessments of second-month Cash BFOE (PCAAR00) and BFOE CFD differentials (PCAKA00, PCAKC00, PCAKE00, PCAKG00, AAGLU00, AAGLV00, AALCZ00).

CPC Blend CIF Augusta vs BTC Dtd Strip <AAHPL00> assessment rationale:

Platts assessed CPC Blend 10 cents/b higher, reflecting strengthening heard indications published through the day and in the absence of indications testing the Nov. 20 assessment.

Exclusions: None